One hub for the whole bio-economy.
News, knowledge and practical tools across biotech, food-tech, agri-tech, probiotics, personalized medicine, bioprocessing and investment — with an AI assistant that helps you build.
Free to join · scientists, engineers, founders & investors welcome
Subscribe for the bio-economy, in your inbox
Get sector news, national biomanufacturing policies (GFI, BioE3, EU Biotech Act & more), and new bioprocess calculation tools — free, straight to your inbox.
Explore by sector
Each sector has its own colour, news and knowledge. Pick yours.
Therapeutics, genomics, synthetic biology and the science powering it all.
News & knowledge →Precision fermentation, alternative proteins and the future of food.
News & knowledge →Biologicals, crop science and sustainable agriculture.
News & knowledge →Microbiome, live cultures and functional health.
News & knowledge →Cell & gene therapy, diagnostics and precision care.
News & knowledge →Upstream, downstream, scale-up and biomanufacturing.
News & knowledge →Funding rounds, deals, M&A and the money moving the sector.
News & knowledge →Breakthroughs, publications and the frontier of discovery.
News & knowledge →National biomanufacturing strategies and public investment — GFI, India's BioE3, the US Bioeconomy initiative, the EU Biotech Act and more.
News & knowledge →Artificial intelligence and machine learning across the bio-economy — AI drug discovery, protein design, genomics, and smart bioprocessing.
News & knowledge →Market pulse — the sector, summarised
An AI-curated feed of the breakthroughs, funding rounds, approvals and deals moving biotech, food-tech, agri-tech and beyond — so you spend less time searching and more time building.
Everything the sector needs, in one place
Articles
Curated reading from the sector's best blogs and journals — biotech, bioprocessing, food-tech and agri-tech.
Open →🧮Bioprocess tools
Upstream & downstream calculators, scale-up, and AI-assisted URS document generators.
Open →📰Market news
Live headlines, deals and breakthroughs from across the entire life-sciences sector, updated daily.
Open →🤝Community
Connect with scientists, engineers, founders and investors solving the same problems.
Open →Latest articles
View all →Trialynx Wins DPHARM Idol Disrupt 2026
Trialynx takes home the DPHARM Idol Disrupt award from the 2026 DPHARM conference.
By Allyson AdamsCellares links with GenomeFrontier to test automation approach for virus-free CAR-Ts
Cellares is partnering with Taiwanese biotech GenomeFrontier Therapeutics to evaluate the integrated contract developer and manufacturer’s cell shuttle platform for use in the production of virus-free CAR-T therapies.
By Joseph KeenanVera’s strong phase 3 IgAN data for Trutakna intensify kidney disease rivalry
New phase 3 data show Vera Therapeutics’ Trutakna successfully stabilizes kidney function in IgA nephropathy patients, mirroring an earlier clinical success from Otsuka’s Voyxact and heating up competition in a rapidly evolving market race.
By Angus LiuJoin the people building the bio-economy
Create a free account to read every article, use the tools, follow your sectors, and grow with the community.
Create your free account